Researchers identify the basic principles of serotonin transport in nerve cells

Drugs known as antidepressants target the serotonin transporter in nerve cells and are among the most commonly prescribed medicines worldwide, but are sometimes associated with significant side effects.

Siegfried successfully completes acquisition of an early-phase CDMO in Wisconsin (US) – Biotech Investments

Siegfried AG / Key word(s): Acquisition Siegfried successfully completes acquisition of an early-phase CDMO in Wisconsin (US) 02.07.2024 / 06:30 CET/CEST Siegfried (SIX: SFZN) has

July 3, 2024

NIH awards $2.1 million to UCLA to end the HIV epidemic

The National Institutes of Health (NIH) has granted $2.1 million to UCLA’s Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) and the UCLA-CDU Center

November 2, 2023

Argenx wins second FDA approval for Vyvgart in autoimmune nerve disease

After a string of clinical failures, the Dutch biotech argenx landed a much-needed win on Friday when the FDA approved its autoimmune disease drug, Vyvgart

June 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.